Literature DB >> 1559666

Familial oesophageal leiomyomatosis and nephropathy.

R N Lonsdale1, P F Roberts, R Vaughan, S Thiru.   

Abstract

Four female members of the same family suffering from a rare combination of oesophageal leiomyomatosis and an Alport-like nephropathy are described. The disease is characterized by marked thickening of the oesophageal wall, usually also involving the proximal stomach, with or without discernible leiomyomatous nodule formation. All cases were treated surgically by oesophagectomy with symptomatic relief, and there was no evidence of recurrence on follow-up (2-37 years). The syndrome appears to be dominantly inherited, affects children and young adults, and may also be associated with leiomyomatosis of other viscera. Previously reported cases and possible aetiologies are reviewed, and evidence that this association represents a new variant of Alport's syndrome is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1559666     DOI: 10.1111/j.1365-2559.1992.tb00941.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

Review 1.  Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis.

Authors:  Markku Miettinen
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

2.  Leiomyomatosis of the esophagus: experience over a decade.

Authors:  Vikas Gupta; Anupam Lal; Saroj K Sinha; Ritambhra Nada; Narendar M Gupta
Journal:  J Gastrointest Surg       Date:  2008-09-26       Impact factor: 3.452

3.  Esophageal leiomyomatosis -- an unusual cause of pseudoachalasia.

Authors:  S Ray; S Singh Saluja; R Gupta; T Kanti Chattopadhyay
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

4.  Esophageal leiomyomatosis combined with intrathoracic stomach and gastric volvulus.

Authors:  Firas W Obeidat; Reinhold A Lang; Florian Löhe; Christian Graeb; Carsten Rist; Karl-Walter Jauch; Tanija K Hüttl; Thomas P Hüttl
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.